Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L26 like 1 (RPL26L1) is a protein encoded by the human RPL26L1 gene and classified as a ribosomal protein with high sequence similarity to ribosomal protein L26. It functions as a structural constituent of the ribosome, participating in translation and RNA binding, but is not currently characterized as a therapeutic target or associated with direct disease roles. Alternative splicing of the gene produces multiple transcript variants encoding the same protein, and it is included among proteins contributing to ribosome structure and cellular protein synthesis. No drugs, biomarkers, or safety concerns are recognized for this molecule.
Not applicable (no drugs or direct modulators known)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L26 like 1 (RPL26L1).